Wissenschaftlicher Beirat – NCT Dresden

Scientific Advisory Board

The joint Scientific Advisory Board of both NCT sites in Dresden and Heidelberg evaluates scientific results and strategically supports NCT in all important aspects. The Advisory Board advises the cross-regional steering committee and the directorates of the NCT Heidelberg and the NCT/UCC Dresden in all scientific and clinical matters as well as conceptional questions. It consists of renowned clinicians and scientists from national and international institutions, some of which connect clinic and science and others are purely research-oriented. 

Members of the Scientific Advisory Board

Prof. Raymond DuBois (Chairman)
The Biodesign Institute Arizona University, USA

Prof. Robert Bristow
Manchester Cancer Research Centre
The University of Manchester, UK

Prof. David Gonzalez de Castro
Queen’s University, Belfast, UK

Prof. Ruggero de Maria
Alleanza Contro il Cancro (ACC)
Roma, Italy

Prof. Alexander Eggermont
Institute de Cancérologie Gustave Roussy, Frankreich

Prof. Michelle Le Beau
The University of Chicago Comprehensive Cancer Center (UCCCC)
The University of Chicago, USA

Prof. Claudia Lengerke
Departement of Biomedicine
University Hospital Basel, Switzerland

Prof. Elaine Mardis
McDonnell Genome Institute
Washington University in St. Louis, USA

Prof. Cornelis J.M. Melief
Leiden University Medical Center, Niederlande

Prof. Radhe Mohan
UT MD Anderson Cancer Center, USA

Prof. Michael Molls
Technische Universität München, Deutschland

Prof. Ulrik Ringborg
Cancer Center Karolinska, Karolinska University Hospital, Schweden

Prof. Yardena Samuels
Department of Moleular Cell Biology
The Weizmann Institute of Science, Israel

Prof. Tom Sellers
H. Lee Moffitt Cancer Center &  Research Institute, USA

Prof. Paresh Vyas
Oxford University Hospital, UK